Literature DB >> 2564902

Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection.

P Muir1, F Nicholson, A J Tilzey, M Signy, T A English, J E Banatvala.   

Abstract

By means of two different IgM-capture assays, enterovirus-specific IgM responses were shown in 9 of 14 (64%) patients with chronic relapsing pericarditis. This finding suggests persistent enterovirus infection, particularly coxsackie B virus infection. IgM responses persisted for at least 1 year and for up to 10 years after onset of symptoms. In contrast, patients with acute enterovirus infections, including acute pericarditis, had transient responses. Among patients with acute pericarditis, the level of IgM antibody was significantly higher in those who subsequently relapsed (mean 1.21, range 0.6-2.0 optical density [OD] units) than in those who did not (0.4, 0.2-0.9 OD units; p less than 0.01). Of 86 patients with dilated cardiomyopathy, 28 (33%) showed enterovirus-specific IgM responses which were present for up to 19 months before transplantation and persisted up to 4 years afterwards. Although the distribution of HLA types in these patients was similar to that in the general population, the frequency of the HLA A2 haplotype was significantly higher in those who were IgM positive. IgM antibody was significantly more common in those who had had symptoms for longer than a year before transplantation than in those with a shorter duration of symptoms (1 of 21 vs 8 of 23; p less than 0.02). Persistent virus-specific serum IgA responses were also shown in patients with chronic cardiac disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564902     DOI: 10.1016/s0140-6736(89)92270-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

Review 1.  Influence of myocarditis on left ventricular function.

Authors:  K L Baughman
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

2.  Human astrocytic cells support persistent coxsackievirus B3 infection.

Authors:  Xiaowei Zhang; Zhenhua Zheng; Bo Shu; Xijuan Liu; Zhenfeng Zhang; Yan Liu; Bingke Bai; Qinxue Hu; Panyong Mao; Hanzhong Wang
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

3.  Myocardial collagen network in dilated cardiomyopathy. Morphometry and scanning electron microscopy study.

Authors:  M A Heneghan; D Malone; P A Dervan
Journal:  Ir J Med Sci       Date:  1991-12       Impact factor: 1.568

4.  Coxsackie B virus and postviral fatigue syndrome.

Authors:  P Muir; F Nicholson; J E Banatvala; P J Bingley
Journal:  BMJ       Date:  1991-03-16

5.  Myocarditis--a controversial disease.

Authors:  N S Peters; P A Poole-Wilson
Journal:  J R Soc Med       Date:  1991-01       Impact factor: 5.344

6.  Myalgic encephalomyelitis--a persistent enteroviral infection?

Authors:  E G Dowsett; A M Ramsay; R A McCartney; E J Bell
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 7.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

Review 8.  Link between enteroviruses and dilated cardiomyopathy: serological and molecular data.

Authors:  P J Keeling; S Tracy
Journal:  Br Heart J       Date:  1994-12

9.  Similar prevalence of enteroviral genome within the myocardium from patients with idiopathic dilated cardiomyopathy and controls by the polymerase chain reaction.

Authors:  P J Keeling; S Jeffery; A L Caforio; R Taylor; G F Bottazzo; M J Davies; W J McKenna
Journal:  Br Heart J       Date:  1992-12

10.  Detection of enterovirus capsid protein VP1 in myocardium from cases of myocarditis or dilated cardiomyopathy by immunohistochemistry: further evidence of enterovirus persistence in myocytes.

Authors:  Hongyi Zhang; Yanwen Li; Dougal R McClean; Peter J Richardson; Richard Florio; Mary Sheppard; Karen Morrison; Najma Latif; Michael J Dunn; Leonard C Archard
Journal:  Med Microbiol Immunol       Date:  2003-11-22       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.